Literature DB >> 32611585

The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications.

Laneke Luies1, Ilse du Preez2.   

Abstract

Clinical symptoms of active tuberculosis (TB) can range from a simple cough to more severe reactions, such as irreversible lung damage and, eventually, death, depending on disease progression. In addition to its clinical presentation, TB has been associated with several other disease-induced systemic complications, such as hyponatremia and glucose intolerance. Here, we provide an overview of the known, although ill-described, underlying biochemical mechanisms responsible for the clinical and systemic presentations associated with this disease and discuss novel hypotheses recently generated by various omics technologies. This summative update can assist clinicians to improve the tentative diagnosis of TB based on a patient's clinical presentation and aid in the development of improved treatment protocols specifically aimed at restoring the disease-induced imbalance for overall homeostasis while simultaneously eradicating the pathogen. Furthermore, future applications of this knowledge could be applied to personalized diagnostic and therapeutic options, bettering the treatment outcome and quality of life of TB patients.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  clinical symptoms; disease mechanisms; omics; systemic complications; tuberculosis

Mesh:

Year:  2020        PMID: 32611585      PMCID: PMC7331478          DOI: 10.1128/CMR.00036-20

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  105 in total

1.  Bronchial Stenosis in Pulmonary Tuberculosis.

Authors:  C H Andrews
Journal:  Can Med Assoc J       Date:  1935-07       Impact factor: 8.262

2.  Microbiota regulates immune defense against respiratory tract influenza A virus infection.

Authors:  Takeshi Ichinohe; Iris K Pang; Yosuke Kumamoto; David R Peaper; John H Ho; Thomas S Murray; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

3.  The oral glucose tolerance test in patients with respiratory infections.

Authors:  O K Başoğlu; F Bacakoğlu; G Cok; A Sayiner; M Ateş
Journal:  Monaldi Arch Chest Dis       Date:  1999-08

4.  The significance of glucose intolerance in pulmonary tuberculosis.

Authors:  P O Oluboyo; R T Erasmus
Journal:  Tubercle       Date:  1990-06

5.  Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas.

Authors:  Adriana Pérez; H Shelton Brown; Blanca I Restrepo
Journal:  Am J Trop Med Hyg       Date:  2006-04       Impact factor: 2.345

Review 6.  Cachexia: pathophysiology and clinical relevance.

Authors:  John E Morley; David R Thomas; Margaret-Mary G Wilson
Journal:  Am J Clin Nutr       Date:  2006-04       Impact factor: 7.045

Review 7.  Mycobacterium tuberculosis metabolism.

Authors:  Digby F Warner
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-11       Impact factor: 6.915

8.  Decreased serum 5-oxoproline in TB patients is associated with pathological damage of the lung.

Authors:  Nanying Che; Jianhua Cheng; Haijing Li; Zhiguo Zhang; Xuxia Zhang; Zhixin Ding; Fangting Dong; Chuanyou Li
Journal:  Clin Chim Acta       Date:  2013-04-19       Impact factor: 3.786

Review 9.  Interactions between the microbiota and the immune system.

Authors:  Lora V Hooper; Dan R Littman; Andrew J Macpherson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

10.  Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.

Authors:  A R Martineau; A M Nanzer; K R Satkunam; G E Packe; S J Rainbow; Z J Maunsell; P M Timms; T R Venton; S M Eldridge; R N Davidson; R J Wilkinson; C J Griffiths
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

View more
  6 in total

1.  Intelligence Classification Algorithm-Based Drug-Resistant Pulmonary Tuberculosis Computed Tomography Imaging Features and Influencing Factors.

Authors:  Yanping Jiang; Xinguo Zhao; Zhengfei Fan
Journal:  Comput Intell Neurosci       Date:  2022-05-19

2.  Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease.

Authors:  Huali Jiang; Li Li; Weijie Chen; Benfa Chen; Heng Li; Shanhua Wang; Min Wang; Yi Luo
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566

3.  Epidemiology and Control of diabetes - tuberculosis comorbidity in Eswatini: protocol for the prospective study of tuberculosis patients on predictive factors, treatment outcomes and patient management practices.

Authors:  Victor Williams; Alinda Vos; Kennedy Otwombe; Diederick E Grobbee; Kerstin Klipstein-Grobusch
Journal:  BMJ Open       Date:  2022-06-21       Impact factor: 3.006

4.  Associations of hyponatremia and SIADH with increased mortality, young age and infection parameters in patients with tuberculosis.

Authors:  Christina Bal; Daniela Gompelmann; Michael Krebs; Lukasz Antoniewicz; Claudia Guttmann-Ducke; Antje Lehmann; Christopher Oliver Milacek; Maximilian Robert Gysan; Peter Wolf; Maaia-Margo Jentus; Irene Steiner; Marco Idzko
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

Review 5.  Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021.

Authors:  Victor Williams; Chukwuemeka Onwuchekwa; Alinda G Vos; Diederick E Grobbee; Kennedy Otwombe; Kerstin Klipstein-Grobusch
Journal:  Glob Health Action       Date:  2022-12-31       Impact factor: 2.996

6.  Diagnosis of Mycobacterium tuberculosis Septic Shock in Patients With Anti-synthetase Syndrome Based on Next-Generation Sequencing: A Case Report and Literature Review.

Authors:  Limin Sun; Ziyue Yang; Fei Yang; Zhenhua Wang; Hongqiang Li; Huifen Wang; Tongwen Sun
Journal:  Front Med (Lausanne)       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.